A Phase I/11 Study of Gemtuzumab Ozogamicin (Myelotarg) given in Conjunction with Busulfan and Cytoxan in Relapsed or High-Risk Patients with Acute Myeloid Leukemia (AML)

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/01 → …

Funding

  • University of Miami, Sylvester Comprehensive Cancer Center